Not provided
Not provided
Not provided
Not provided
Not provided
Slow recruitment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Hospitals Cleveland Medical Center | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of study is to evaluate whether Doppler ultrasound can accurately identify patients who are at risk of recurrent bleeding, who will require endoscopic therapy, and who will fail endoscopic therapy.
Bleeding peptic ulcer is a life-threatening emergency. Endoscopic therapy is a proven technique in the acute hemostasis of bleeding ulcers. Currently there is no objective assessment of adequacy of endoscopic therapy. Endoscopic Doppler ultrasound enables endoscopists in detecting blood flow in a vessel beneath an ulcer. A persistent signal after endoscopic therapy predicts recurrent bleeding. The current study proposes to compare assessment of ulcer base using either Doppler ultrasound or endoscopists' interpretation of ulcer floors. The trial design is one of a prospective randomized controlled cross-over study in which patients with severe upper gastrointestinal bleeding and documented peptic ulcers at endoscopy are enrolled.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Doppler ultrasound | Active Comparator |
| |
| No Doppler ultrasound | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Doppler ultrasound probe | Device | Applying to ulcer base to assess the blood flow underneath the ulcer |
|
| Measure | Description | Time Frame |
|---|---|---|
| Recurrent bleeding | Within 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Length of stay | Within 56 days | |
| ICU utilization | Within 56 days | |
| Blood Transfusion during hospital |
Not provided
Inclusion Criteria:
Clean base ulcer with severe upper GIB (defined as melaena, hematochezia, hematemesis, and/or gross blood in NG lavage), and any one of the following:
Endoscopically confirmed bleeding from GU, DU, pyloric ulcer, or anastomotic ulcer
Pt can either have primary or secondary acute UGI haemorrhage
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| James Y Lau, MD | Prince of Wales Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Endoscopy Center, Prince of Wales Hospital | Hong Kong SAR | China |
Not provided
| ID | Term |
|---|---|
| D010438 | Peptic Ulcer Hemorrhage |
| ID | Term |
|---|---|
| D006471 | Gastrointestinal Hemorrhage |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D006470 | Hemorrhage |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Within 56 days |
| Need for urgent/emergent ulcer surgery for bleeding | Within 56 days |
| Need for angiographic treatment of bleeding | Within 56 days |
| Death | within 56 days |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |